Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

How I treat essential thrombocythemia

E Rumi, M Cazzola - Blood, The Journal of the American …, 2016 - ashpublications.org
Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm that may be
complicated by vascular events, including both thrombosis and bleeding. This disorder may …

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

C Williamson, M Nana, L Poon, L Kupcinskas… - Journal of …, 2023 - Elsevier
Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …

NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018

RA Mesa, C Jamieson, R Bhatia, MW Deininger… - Journal of the National …, 2017 - jnccn.org
Myeloproliferative neoplasms (MPNs) are a group of heterogeneous disorders of the
hematopoietic system that include myelofibrosis (MF), polycythemia vera (PV), and essential …

The essential thrombocythemia in 2020: what we know and where we still have to dig deep

V Accurso, M Santoro, S Mancuso… - Clinical Medicine …, 2020 - journals.sagepub.com
The Essential Thrombocythemia is a Chronic Philadelphia-negative Myeloproliferative
Neoplasm characterized by a survival curve that is only slightly worse than that of age-and …

Myeloproliferative neoplasms and pregnancy: overview and practice recommendations

N Gangat, A Tefferi - American journal of hematology, 2021 - Wiley Online Library
Pregnancy in the context of myeloproliferative neoplasms (MPN) poses unique fetal and
maternal challenges. Current literature in this regard mostly involves essential …

Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study

S Alimam, S Bewley, LC Chappell… - British journal of …, 2016 - Wiley Online Library
The reported higher risk of maternal and fetal complications in women with
myeloproliferative neoplasms (MPN) poses challenge during pregnancy. A national …

How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy

SE Robinson, CN Harrison - British journal of haematology, 2020 - Wiley Online Library
The combined incidence of classical Philadelphia‐negative myeloproliferative neoplasm
(MPN) is 6–9/100 000 with a peak frequency between 50 and 70 years. MPN is less frequent …